miproducts
Xal-Ease
Xal-Ease is an aid used for the delivery of glaucoma eye drops. The device holds the Xalatan (latanoprost) or Xalacom (latanoprost/ timolol) bottle and helps correctly position it over the eye to deliver a single drop of medication.
Xal-Ease is provided free of charge for patients prescribed Xalatan or Xalacom to assist medication adherence.
Contact: Aspen Australia (AUS) 1300 659 646, or scan the QR code:
Before prescribing, please review product information available by calling (AUS) 1300 659 646, or scanning the QR codes below.
PBS Information: Xalatan (latanoprost 0.005% eye drops, 2.5 mL) and Xalacom (latanoprost 0.005% + timolol 0.5% eye drops, 2.5 mL) are listed on the Pharmaceutical Benefits Scheme (PBS) as antiglaucoma preparations and miotics.
AU-LAT-12-25-00002. Prepared Dec 2025.
Next Gen MiSight 1 Day for Myopia
CooperVision, has launched its new myopia control soft contact lens, MyDay MiSight 1 day, that combines the proven ActivControl Technology of MiSight 1 day with the advanced silicone hydrogel material used in MyDay lenses.*1 The lens is available in Australia and New Zealand.
The introduction of MyDay MiSight 1 day builds on the success of MiSight 1 day, the number one fitted soft contact lens brand for myopia control, worn by over 200,000 children worldwide.†2,3 The lens provides the same clear vision and myopia control benefits of the MiSight 1 day design, with excellent comfort, and enhanced ease of handling and breathability over the original MiSight 1 day.‡§◊4,5
Wearers of the new lens will also benefit from a built-in UV inhibitor to help protect the cornea and crystalline lens against transmission of harmful UV radiation.¶
Combatting A Growing Challenge With myopia projected to affect half the world’s population by 2050, CooperVision said a coordinated global response is needed to combat the corresponding clinical and societal impacts.6 “CooperVision has spent over a decade building expertise in myopia management across more than 40 countries,” said Michelle North, General Manager CooperVision Australia and New Zealand. “MyDay MiSight 1 day brings together our most advanced contact lens material with an optical design already trusted by hundreds of thousands of parents and children worldwide.*1* Myopia is irreversible and typically progresses rapidly in younger children.7 Wearing time is critical for effective myopia control, yet children do not consistently wear their spectacles.”**8
Ms North said, “contact lenses make it easy for children to achieve the maximum wearing time for myopia control”.††4,9,10 She highlighted a clinical trial, featuring ActivControl technology, in which children were required to wear contact lenses at least 10 hours per day six days per week. The trial found that children wore their lenses for 13–14 hours per day and more than 6.5 days per week.‡‡9
Contact: CooperVision Account Manager
Footnotes and references available at mivision.com.au.